San Jose, Costa Rica, November 2026 – Santhera Pharmaceuticals (SIX: SANN), a Swiss specialty pharmaceutical company focused on rare diseases, and SteinCares, a leading specialty healthcare company in Latin America, have announced an exclusive distribution agreement to bring AGAMREE® (vamorolone), an innovative treatment for Duchenne muscular dystrophy (DMD) to selected